Lipophilicity of Beta‐Adrenocepter Antagonists: A New Classification Scheme for Clinical Use

Publisher： John Wiley & Sons Inc

E-ISSN： 2055-2335|37|2|98-101

ISSN： 1445-937x

Source： JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol.37, Iss.2, 2007-06, pp. : 98-101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antagonists of TNF action: clinical experience and new developments

By Kontermann Roland E   Scheurich Peter   Pfizenmaier Klaus  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 3, 2009-03 ,pp. : 279-292

Informa Healthcare

Access to resources Recommend Favorite

Progress in the Use of HPLC for Evaluation of Lipophilicity

By  

Current Computer - Aided Drug Design, Vol. 2, Iss. 4, 2006-01 ,pp. : 327-340

Bentham Science Publishers

Access to resources Recommend Favorite

New developments in the use of peptide gonadotropin-releasing hormone antagonists versus agonists

By Schultze-Mosgau Askan   Griesinger Georg   Altgassen Christopher   von Otte Soeren   Hornung Daniela   Diedrich Klaus  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 9, 2005-09 ,pp. : 1085-1097

Informa Healthcare

Access to resources Recommend Favorite

Epoetin Beta: A Review of its Clinical Use in the Treatment of Anaemia in Patients with Cancer

By Cheer S.M.   Wagstaff A.J.  

Drugs, Vol. 64, Iss. 3, 2004-01 ,pp. : 323-346

Adis International

Access to resources Recommend Favorite

The Influence of Lipophilicity on the Classification of Antitumor Acridinones Evaluated by Principal Component Analysis

By  

Current Pharmaceutical Analysis, Vol. 8, Iss. 2, 2012-01 ,pp. : 157-174

Bentham Science Publishers

Access to resources Recommend Favorite